Zachariah Jonasson

Seaflower makes life cycle investments in start-up and early-stage life science and medical technology companies in the following areas: biopharmaceuticals, biotechnology platforms, computational biology, medical devices and e-Pharma. The firm occasionally considers investments in healthcare information technology companies, but does not invest in healthcare service companies. They will not consider investments in consumer-oriented healthcare companies. Seaflower primarily invests in companies located in New England, the Mid-Atlantic, the Great Lakes area, Eastern Canada and the Southeast. They also consider co-investment opportunities alongside a strong local lead investor in other parts of the Midwest, the Mountain States, and occasionally the West Coast. Seaflower does not consider investment opportunities outside of North America

Operates an online database of clinical trials

Functions as a College/University

Provides biopharmaceutical product, device, and health care development and commercialization consulting services

Develops and commercializes drug delivery solutions for the treatment of diabetes

Convergent Ventures focuses on early-stage equity investments in the life sciences sector. The firm is particularly interested in drug discovery and development, R&D platforms and research services. They may also consider opportunities in other fields when they feel they have special expertise in that field. Convergent Ventures focuses on investments in California and Israel. In addition to creating and running new life-science companies, the firm also provides strategic and management consulting services to life-science start-up companies and larger, more established businesses.

Phoenix Venture Partners invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital requirements.

Operates as a central bank

Develops green formulation technologies for improving agricultural production

Engages in development of cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry

Develops diagnostic medical devices for eye care

Oregon Translational Research & Development Institute (OTRADI) is dedicated to transforming scientific research from laboratories into commercial ventures, focusing on biotechnology, health, and life sciences. The private company is based in Portland. It operates the Bioscience Incubator (OBI), providing startups and scientists access to entrepreneurial mentoring, advanced facilities, shared equipment, and event spaces. OTRADI offers programs such as the Biomentoring Initiative, connecting early-stage life science companies with experienced volunteer mentors who provide advisory support on business planning, regulatory issues, funding, and marketing. The OBI Biomembership program supports founders and entrepreneurs with brand visibility, networking opportunities, access to business tools, mentorship, and participation in leadership roundtables. OTRADI hosts events to foster community engagement and showcase innovative resident startups developing technologies like AI-driven medical solutions, diagnostics, therapeutics, and medical devices. Its resource library features webinars and panel discussions on drug development, regulatory strategies, funding, intellectual property, diversity, and business operations for biotech startups. The institute acknowledges indigenous lands and promotes decolonization within the bioscience industry.

Produces water repellent textiles

Manufactures microbial monitoring systems

Develops software and radar based fall detection & personal emergency response systems hardware products

Develops biologic medicines

Develops medicines